Serum Institute of India
Indian biotechnology and biopharmaceuticals company
Serum Institute of India ▸ Facts ▸ Comments ▸ News ▸ Videos
Novavax vaccine over 90% effective in U.S. trial
Credit: Reuters - Politics Duration: 01:41Published
Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab | Oneindia News
Credit: Oneindia Duration: 01:48Published
BJP Minister Prakash Javadekar says India will be fully vaccinated by December 2021 | Oneindia News
Credit: Oneindia Duration: 02:01Published
Covid recoveries more than daily active cases | Highest single-day death: 4,329 | Oneindia News
Credit: Oneindia Duration: 03:00Published
UK agreed to expand partnership on vaccines: MEA
Credit: ANI Duration: 01:13Published
Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge
Credit: HT Digital Content Duration: 02:05Published
Who threatened him?, asks Nana Patole on Adar Poonawalla's threat claims
Credit: ANI Duration: 01:36Published
‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls
Credit: HT Digital Content Duration: 01:50Published
‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India
Credit: HT Digital Content Duration: 01:43Published
India receives first lot of Sputnik V vaccine
Credit: ANI Duration: 02:00Published
Have asked for 67 lakh doses each from both vaccine manufacturing companies: CM Kejriwal
Credit: ANI Duration: 01:50Published
Phase 3 vaccination drive to delay in Karnataka due to vaccine shortage
Credit: ANI Duration: 01:38Published
Tripura needs 32 lakh vaccine doses for 100% vaccination of people between 18-44 years
Credit: ANI Duration: 01:42Published
Vaccine manufacturers will supply vaccine by May end: Jharkhand Health Minister
Credit: ANI Duration: 01:44Published
After SII, Bharat Biotech reduces Covaxin price; Rs 400 per dose for state govts
Credit: HT Digital Content Duration: 01:25Published
Adar Poonawalla 'life threat' | SII CEO gets Y security cover | Oneindia News
Credit: Oneindia Duration: 01:30Published
Covid: SII reduces Covishield price, vaccine now at Rs 300 per dose for states
Credit: HT Digital Content Duration: 01:27Published
Rajasthan needs 7 crore doses for 3rd phase of COVID vaccination drive
Credit: ANI Duration: 02:07Published
You Might Like
SII, Bharat Biotech seek hike in government price for Covid vaccinesSerum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals..
COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacyNovavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
Covid-19: Novavax set for India launch with Serum Institute of India as manufacturing partnerThe uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major destination for the shots with the Serum..
Covishield produces more antibodies than Covaxin, finds studyCovishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in..
COVID-19: DCGI approves Serum Institute to manufacture Sputnik V vaccine in IndiaSII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V.
Serum Institute gets DCGI's nod to manufacture Covid jab Sputnik V in India
Also reported by •DNA
Serum Institute of India pushes for indemnity after foreign companies’ request
US to ease Covid vaccine input supply: Kamala Harris to PM ModiUS Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax..
Serum Institute seeks indemnity from liability; says 'rules should be same for everyone': Sources
After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: SourcesAmid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their Covid-19 jabs in India, the Serum Institute of India (SII) has also sought protection..
HC asks Maharashtra to address security concerns raised by SII CEO
SII unable to supply Covishield vaccine, Maldives looks elsewhere
Covid-19: Government plans 1 crore daily vaccines from middle of JulyThe Centre plans to ramp up vaccination against Covid-19 on a “mission mode”, targeting an average of around 1 crore inoculations per day from around mid-July or August as vaccine supplies are..
Centre creating 'artificial scarcity' of Covid vaccines to benefit Bharat Biotech, SII: AAP
Serum Institute of India, Bharat Biotech producing minimum 8 crore doses/month, yet only 5 crore will be given by May-endThe government in an affidavit in the Supreme Court earlier this month averred that Serum Institute of India (SII) was producing 6.5 crore doses of Covishield a month and Bharat Biotech was producing 2..
Serum Institute disassociates itself from its executive's remarks on Covid vaccination drive
Never exported vaccines at the cost of people of India: SIIDefending its decision to export vaccines, Serum Institute of India (SII) said on Tuesday that it was based on several factors, including the build-up of a large stockpile in January, while cases were..
Serum Institute CEO Adar Poonawalla finally breaks silence on export of vaccines"Our government extended support wherever possible during this period," Serum Institute said in a statement.
WHO reminds Serum Institute of its Covax commitments amidst devastating Covid-19 outbreak, soaring demand in IndiaWHO chief Tedros Adhanom Ghebreyesus has said that once the devastating Covid-19 outbreak in India recedes, the Serum Institute of India will need to "get back on track and catch up" on its delivery..
No financial aid given to SII & Bharat Biotech: Govt in SC
Govt rejects SII plea to export 50 lakh doses of Covishield to UKDespite the international pressure and several rounds of negotiations by Serum Institute of India (SII), the government has turned down the request from SII to export 50 lakh doses of Covishield to UK..
At Rs 700-Rs 1,500, price of Covid vaccine in India’s private sector among costliestFrom Rs 250, the cost of vaccines in the private sector has shot up by up to six times. It now ranges from Rs 700-900 for Covishield manufactured by the Serum Institute of India (SII) and Rs..
Plea in Bombay HC seeks Z-plus security for SII CEO Adar Poonawalla
Ahead of India-UK summit, Boris Johnson announces 1 billion pound trade dealThe UK-India trade deals include an investment of 240 million pounds by the Pune-based Serum Institute of India (SII).
Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says governmentThe government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid vaccine between May and July. While..
Not possible to ramp up COVID vaccine production overnight: SII CEO Adar PoonawallaAdar Poonawalla issued a statement after some of his comments on vaccine production were misinterpreted.
Also reported by •IndiaTimes
Media reports alleging Centre hasn't placed any fresh order for Covid-19 vaccines incorrect: Health ministry"The news reports suggest that the last order placed with the two vaccine makers (100 million doses with SII and 20 million doses with Bharat Biotech) was in March 2021. These media reports are..
Serum Institute of India CEO Adar Poonawalla makes BIG statement over COVID-19 vaccine shortageAccording to a Financial Times report, SII CEO said that production of vaccines would increase in July from about 60-70 million to 100mln per month.
Serum Institute CEO Adar Poonawalla: Will return to India in a few days"Had an excellent meeting with all our partners & stakeholders in the UK. Meanwhile, pleased to state that Covishiled's production is in full swing in Pune. I look forward to reviewing operations upon..
Serum Institute of India CEO Adar Poonawalla flies to London to after receiving 'threats' from CMs, corporates leadersPoonawalla said that he is planning to stay in the UK for a long time because of constant threats he's getting from CMs and other corporate leaders.
Covishield production in full swing, says SII's Adar Poonawalla
Serum Institute plans to start Covid vaccine production outside India: ReportThe Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief..
After SII, Bharat Biotech slashes price of Covaxin for states to Rs 400Earlier, Bharat Biotech had priced one dose of Covaxin for the state governments at Rs 600 and for private hospitals at Rs 1,200.
SII cuts vaccine price for states to Rs 300/dose, terms it a ‘philanthropic gesture’Facing a public outcry over pricing of Covishield, Serum Institute of India on Wednesday announced a 25% or Rs 100 reduction in its price for state governments, describing it as a “philanthropic..
Amid threats, Centre provides Y category security to SII CEO Adar PoonawallaCovishield, one of the two COVID-19 vaccines used in India's COVID-19 vaccination drive, is being manufactured by SII.
Serum Institute CEO Adar Poonawalla gets 'Y' category security cover
Serum Institute reduces Covishield price for states from Rs 400 to Rs 300 per doseSerum Institute of India on Wednesday announced that it was reducing the price of its Covishield vaccine from Rs 400 to Rs 300 per dose for the states as a "philanthropic gesture". "As a philanthropic..
SII cuts price of COVID-19 vaccine Covishield for states from Rs 400 to Rs 300The Serum Institute of India, manufacturer of COVID-19 vaccine Covishield has reduced the price to the states from Rs 400 to Rs 300 per dose.
Covid-19: US diverting raw material to Serum Institute for vaccine productionThe United States on Monday rolled out a series of supportive measures to help India's titanic fight against the Covid-19 upsurge, including diverting raw material to the Serum Institute to India to..
Govt asks Serum Institute, Bharat Biotech to lower price of Covid-19 vaccines: Official sourcesThe central government on Monday asked the Serum Institute and Bharat Biotech to lower prices of their Covid-19 vaccines amid criticism from various states who objected to profiteering during such a..
Rs 400 for state, Rs 600 for private: Serum Institute releases rate card of Covishield
Covid-19: Most vaccines may cost 700-1,000 per doseMost companies are expected to price the Covid-19 vaccines around Rs 700-1,000 per dose, when they roll out the jabs in the private market later this year, up from the government-mandated price of Rs..
Covid-19: White House refuses to comment on lifting ban on vaccine raw materials export to IndiaThe White House on Monday did not respond to questions on the request by Serum Institute of India to lift export ban on certain raw materials needed for ramping up production of Covid-19 vaccine.
'India to fund capacity boost at Serum Institute as vaccines run short'
Even as Covid vaccine demand rises, firms may take some weeks to up productionIndications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and Bharat Biotech ramp up capacity, some of..
Serum Institute asks government for $403 million to boost AstraZeneca vaccine outputThe Serum Institute of India has asked the government for a grant of 30 billion rupees ($402.97 million) to increase its capacity to make AstraZeneca's Covid-19 vaccine. It is seeking the money to ramp..
EU seeks 10 million AstraZeneca vaccines from India to meet shortfall: Indian sourcehe European Union has asked India to allow it to buy 10 million doses of AstraZeneca's Covid-19 vaccine from Serum Institute of India, a government official told Reuters, the latest sign of growing..
India extends shelf life of AstraZeneca vaccine: ReportIndia's drug regulator has allowed the AstraZeneca Covid-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed..
Covovax trials begin in India, hope to launch it by Sept 2021: Adar PoonawallaSerum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of Covid-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year.
UK’s vaccination drive hit as Serum Institute ‘delays’ supplyThe UK’s vaccine rollout “has been hampered” due to the delay in delivery of a promised second batch of five million doses by the Serum Institute of India. A leaked letter, dated March 17, from..